Literature DB >> 18708481

Screening pregnant women for chlamydia: what are the predictors of infection?

M Y Chen1, C K Fairley, D De Guingand, J Hocking, S Tabrizi, E M Wallace, S Grover, L Gurrin, R Carter, M Pirotta, S Garland.   

Abstract

OBJECTIVES: To determine the risk factors associated with chlamydial infection in pregnancy and the sensitivity and specificity of these when used for selective screening.
METHODS: A prospective, cross-sectional study of pregnant women aged 16-25 years attending four major public antenatal services across Melbourne, Australia. Between October 2006 and July 2007, women were approached consecutively and asked to complete a questionnaire and to provide a first-pass urine specimen for Chlamydia trachomatis testing using PCR.
RESULTS: Of 1180 eligible women, 1087 were approached and 1044 (88%) consented to participate. Among the 987 women for whom a questionnaire and a definitive diagnostic assay were available, the prevalence of chlamydia was 3.2% (95% CI 1.8 to 5.9). In a multiple logistic regression model, more than one sexual partner in the past year (AOR 11.5; 95% CI 7.1 to 18.5) was associated with chlamydia infection. The use of any antibiotic within 3 months (AOR 0.2; 95% CI 0.1 to 0.6) was associated with a decreased risk of infection. Screening restricted to women who reported more than one sexual partner in the past year would have detected 44% of infections in women aged 16-25 years and would have required only 7% of women to be screened. The addition of those women aged 20 years and under would have required 27% of women to be screened and detection of 72% of infections.
CONCLUSIONS: Selective chlamydia screening of pregnant women based on risk factors can improve the yield from screening. However, the potential harm of missed infections among excluded women would need to be considered.

Entities:  

Mesh:

Year:  2008        PMID: 18708481     DOI: 10.1136/sti.2008.030700

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  12 in total

1.  Antibiotic use before chlamydia and gonorrhea genital and extragenital screening in the sexually transmitted infection clinical setting.

Authors:  Nicole H T M Dukers-Muijrers; Genevieve A F S van Liere; Petra F G Wolffs; Casper Den Heijer; Marita I L S Werner; Christian J P A Hoebe
Journal:  Antimicrob Agents Chemother       Date:  2014-10-13       Impact factor: 5.191

2.  Developing a predictive model to prioritize human immunodeficiency virus partner notification in North Carolina.

Authors:  Brooke E Hoots; Pia D M MacDonald; Lisa B Hightow-Weidman; Peter A Leone; William C Miller
Journal:  Sex Transm Dis       Date:  2012-01       Impact factor: 2.830

3.  Chlamydia trachomatis infection during pregnancy associated with preterm delivery: a population-based prospective cohort study.

Authors:  G Ingrid J G Rours; Liesbeth Duijts; Henriette A Moll; Lidia R Arends; Ronald de Groot; Vincent W Jaddoe; Albert Hofman; Eric A P Steegers; Johan P Mackenbach; Alewijn Ott; Hendrina F M Willemse; Elizabeth A E van der Zwaan; Roel P Verkooijen; Henri A Verbrugh
Journal:  Eur J Epidemiol       Date:  2011-05-03       Impact factor: 8.082

4.  Current Status of the Screening of Chlamydia trachomatis Infection Among Japanese Pregnant Women.

Authors:  Shunji Suzuki; Masanobu Tanaka; Hideo Matsuda; Yuki Tsukahara; Yasushi Kuribayashi; Akihiko Sekizawa; Ryoichiro Miyazaki; Osamu Nishii; Akihito Nakai; Nobuko Mizutani; Yoshiaki Kumamoto; Katsuyuki Kinoshita
Journal:  J Clin Med Res       Date:  2015-05-08

5.  Young pregnant women's views on the acceptability of screening for chlamydia as part of routine antenatal care.

Authors:  Jade E Bilardi; Deborah L De Guingand; Meredith J Temple-Smith; Suzanne Garland; Christopher K Fairley; Sonia Grover; Euan Wallace; Jane S Hocking; Sepehr Tabrizi; Marie Pirotta; Marcus Y Chen
Journal:  BMC Public Health       Date:  2010-08-19       Impact factor: 3.295

6.  Chlamydia trachomatis and Adverse Pregnancy Outcomes: Meta-analysis of Patients With and Without Infection.

Authors:  Courtney Olson-Chen; Kripa Balaram; David N Hackney
Journal:  Matern Child Health J       Date:  2018-06

7.  Trends in chlamydia and gonorrhea positivity among heterosexual men and men who have sex with men attending a large urban sexual health service in Australia, 2002-2009.

Authors:  Lenka A Vodstrcil; Christopher K Fairley; Glenda Fehler; David Leslie; Jennifer Walker; Catriona S Bradshaw; Jane S Hocking
Journal:  BMC Infect Dis       Date:  2011-06-05       Impact factor: 3.090

8.  Chlamydia trachomatis incidence and re-infection among young women--behavioural and microbiological characteristics.

Authors:  Jennifer Walker; Sepehr N Tabrizi; Christopher K Fairley; Marcus Y Chen; Catriona S Bradshaw; Jimmy Twin; Nicole Taylor; Basil Donovan; John M Kaldor; Kathleen McNamee; Eve Urban; Sandra Walker; Marian Currie; Hudson Birden; Francis Bowden; Jane Gunn; Marie Pirotta; Lyle Gurrin; Veerakathy Harindra; Suzanne M Garland; Jane S Hocking
Journal:  PLoS One       Date:  2012-05-25       Impact factor: 3.240

Review 9.  The Epidemiological Impact of STIs among General and Vulnerable Populations of the Amazon Region of Brazil: 30 years of Surveillance.

Authors:  Luiz Fernando Almeida Machado; Ricardo Roberto de Souza Fonseca; Maria Alice Freitas Queiroz; Aldemir Branco Oliveira-Filho; Izaura Maria Vieira Cayres-Vallinoto; Antonio Carlos Rosário Vallinoto; Marluísa de Oliveira Guimarães Ishak; Ricardo Ishak
Journal:  Viruses       Date:  2021-05-07       Impact factor: 5.048

Review 10.  The prevalence of Chlamydia trachomatis infection in Australia: a systematic review and meta-analysis.

Authors:  Dyani Lewis; Danielle C Newton; Rebecca J Guy; Hammad Ali; Marcus Y Chen; Christopher K Fairley; Jane S Hocking
Journal:  BMC Infect Dis       Date:  2012-05-14       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.